Advertisement

Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database

Published:February 24, 2021DOI:https://doi.org/10.1016/j.jss.2021.01.027

      Abstract

      Background

      Delirium is a common complication in intensive care unit (ICU) patients, and it can significantly increase the length of hospital stay and cost. Dexamethasone is widely used in various inflammatory diseases and must be used with caution in critically ill patients. Previous studies have shown that the effect of corticosteroid use on the development of delirium in critically ill patients is still controversial, and there is inconclusive conclusion about the effect of dexamethasone on delirium in such patients. Therefore, this study aimed to confirm the effect of dexamethasone use and the dose on the incidence of delirium and patient prognosis in critically ill patients through a large cohort study.

      Methods

      A retrospective cohort study was conducted using data extracted from the Medical Information Mart for Intensive Care III database, which is a large and freely available database of all 46,476 patients who visited Beth Israel Deaconess Medical Center in Boston, Massachusetts, USA and were admitted to the ICU between 2001 and 2012. The primary outcome was the development of delirium, using multivariate logistic regression analysis to reveal the relationship between dexamethasone and delirium. Secondary endpoints were in-hospital mortality, ICU mortality, total length of stay, and length of ICU stay, and the relationship between dexamethasone and prognosis was assessed with Cox proportional hazards models. Propensity score matching with 1:1 grouping was used to eliminate the effect of confounders on both cohorts. The locally weighted scatter plot smoothing technique was used to investigate the dose correlation between dexamethasone and outcomes, subgroup analysis was used to account for heterogeneity, and different correction models and propensity matching analysis were used to eliminate potential confounders.

      Results

      Finally, 38,509 patients were included, and 2204 (5.7%) used dexamethasone. No significant statistical difference was observed in basic demographic information after propensity score matching between the two study groups. A significantly higher incidence of delirium (5.0% versus 3.4%, P < 0.001), increased in-hospital mortality (14.9% versus 10.3%, P < 0.001), ICU mortality (9.0% versus 7.5%, P = 0.008), and longer length of stay and ICU stay were observed in patients taking dexamethasone compared with those not taking dexamethasone. Multivariate logistic and Cox regression analyses confirmed that dexamethasone was significantly associated with delirium (adjusted odds ratio = 1.48, 95% confidence interval [CI] = 1.09-2.00, P = 0.012), in-hospital mortality (adjusted hazard ratio = 1.19, 95% CI = 1.02-1.40, P = 0.032), and ICU mortality (adjusted hazard ratio = 1.62, 95% CI = 1.22-2.15, P = 0.001). Compared with critically ill patients using high-dose dexamethasone, the risk of delirium was lower in the dose less than the 10 mg group, and patients using 10-14 mg may be associated with a lower risk of in-hospital death and the least ICU mortality, length of hospital stay, and ICU stay.

      Conclusions

      This study demonstrated that the use of dexamethasone in critically ill patients exacerbated the occurrence of delirium while increasing the risk of in-hospital death, ICU death, and length of hospital stay, with a lower risk of delirium and a shorter total length of hospital stay with low-dose dexamethasone than with larger doses.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Surgical Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Inouye S.K.
        Clarifying confusion: the confusion assessment method.
        Ann Intern Med. 1990; 113: 941
        • O'Regan N.A.
        • Fitzgerald J.
        • Timmons S.
        • O'Connell H.
        • Delirium M.D.
        A key challenge for perioperative care.
        Int J Surg. 2013; 11: 136
        • Bilotta F.
        • Lauretta M.P.
        • Borozdina A.
        • Mizikov V.M.
        • Rosa G.
        Postoperative delirium: risk factors, diagnosis and perioperative care.
        Minerva Anestesiol. 2013; 79: 1066
        • Smulter N.
        • Lingehall H.C.
        • Gustafson Y.
        • Olofsson B.
        • Engstrom K.G.
        Delirium after cardiac surgery: incidence and risk factors.
        Interact Cardiovasc Thorac Surg. 2013; 17: 790
        • Saczynski J.S.
        • Marcantonio E.R.
        • Quach L.
        • et al.
        Cognitive trajectories after postoperative delirium.
        New Engl J Med. 2012; 367: 30
        • Bettelli G.
        • Neuner B.
        Postoperative delirium: a preventable complication in the elderly surgical patient.
        Monaldi Arch chest Dis. 2017; 87: 842
        • Gosselt A.N.
        • Slooter A.J.
        • Boere P.R.
        • Zaal I.J.
        Risk factors for delirium after on-pump cardiac surgery: a systematic review.
        Crit Care. 2015; 19: 346
        • Santos E.
        • Cardoso D.
        • Neves H.
        • et al.
        Effectiveness of haloperidol prophylaxis in critically ill patients with a high risk of delirium.
        JBI Database Syst Rev Implement Rep. 2017; 15: 1440
        • Sakusic A.
        • O'Horo J.C.
        • Dziadzko M.
        • et al.
        Potentially modifiable risk factors for long-term cognitive impairment after critical illness: a systematic review.
        Mayo Clin Proc. 2018; 93: 68
        • Lee A.
        • Mu J.L.
        • Joynt G.M.
        • et al.
        Risk prediction models for delirium in the intensive care unit after cardiac surgery: a systematic review and independent external validation.
        Brit J Anaesth. 2017; 118: 391
        • Girard T.D.
        • Jackson J.C.
        • Pandharipande P.P.
        • et al.
        Delirium as a predictor of long-term cognitive impairment in survivors of critical illness.
        Crit Care Med. 2010; 38: 1513
        • Leslie D.L.
        • Inouye S.K.
        The importance of delirium: economic and societal costs.
        J Am Geriatr Soc. 2011; 59: S241
        • Dillon S.T.
        • Vasunilashorn S.M.
        • Ngo L.
        • et al.
        Higher C-reactive protein levels predict postoperative delirium in older patients undergoing major elective surgery: a longitudinal nested case-control study.
        Biol Psychiat. 2017; 81: 145
        • Li L.
        • Wang C.
        • Fang M.
        • et al.
        Effects of dexamethasone on post-operative cognitive dysfunction and delirium in adults following general anaesthesia: a meta-analysis of randomised controlled trials.
        BMC Anesthesiol. 2019; 19: 113
        • Smith C.
        • Erasmus P.J.
        • Myburgh K.H.
        Endocrine and immune effects of dexamethasone in unilateral total knee replacement.
        J Int Med Res. 2006; 34: 603
        • Britt R.C.
        Corticosteroid use in the intensive care unit.
        Arch Surg. 2006; 141: 145
        • Holte K.
        • Kehlet H.
        Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications.
        J Am Coll Surg. 2002; 195: 694
        • Dabul L.
        • Droney A.
        • Oms J.
        • Sanchez-Gonzalez M.A.
        Acute changes in mentation in a patient with Hepatic cirrhosis treated with high doses of dexamethasone.
        Cureus. 2017; 9: e1675
        • Kenna H.A.
        • Poon A.W.
        • de Los Angeles C.P.
        • Koran L.M.
        Psychiatric complications of treatment with corticosteroids: review with case report.
        Psychiat Clin Neuros. 2011; 65: 549
        • Mardani D.
        • Bigdelian H.
        Predictors and clinical outcomes of postoperative delirium after administration of dexamethasone in patients undergoing coronary artery bypass surgery.
        Int J Prev Med. 2012; 3: 420
        • Sauer A.M.
        • Slooter A.J.
        • Veldhuijzen D.S.
        • et al.
        Intraoperative dexamethasone and delirium after cardiac surgery: a randomized clinical trial.
        Anesth Analg. 2014; 119: 1046
        • Mardani D.
        • Bigdelian H.
        Prophylaxis of dexamethasone protects patients from further post-operative delirium after cardiac surgery: a randomized trial.
        J Res Med Sci. 2013; 18: 137
        • Schreiber M.P.
        • Colantuoni E.
        • Bienvenu O.J.
        • et al.
        Corticosteroids and transition to delirium in patients with acute lung injury∗.
        Crit Care Med. 2014; 42: 1480
        • Wolters A.E.
        • Zaal I.J.
        • Veldhuijzen D.S.
        • et al.
        Anticholinergic medication use and transition to delirium in critically ill patients.
        Crit Care Med. 2015; 43: 1846
        • Johnson A.E.W.
        • Pollard T.J.
        • Shen L.
        • et al.
        MIMIC-III, a freely accessible critical care database.
        Sci Data. 2016; 3: 160035
        • Zhang Z.
        Accessing critical care big data: a step by step approach.
        J Thorac Dis. 2015; 7: 238
        • Vincent J.L.
        • Moreno R.
        • Takala J.
        • et al.
        The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European society of intensive care medicine.
        Intens Care Med. 1996; 22: 707
        • Metnitz P.G.
        • Moreno R.P.
        • Almeida E.
        • et al.
        SAPS 3--From evaluation of the patient to evaluation of the intensive care unit. Part 1: objectives, methods and cohort description.
        Intensive Care Med. 2005; 31: 1336
      1. Robust locally weighted regression and smoothing scatterplots.
        J Am Stat Assoc. 1979; 74
        • Reade M.C.
        • O'Sullivan K.
        • Bates S.
        • et al.
        Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial.
        Crit Care (Lond Engl). 2009; 13: R75
        • Bledowski J.
        • Trutia A.
        A review of pharmacologic management and prevention strategies for delirium in the intensive care unit.
        Psychosomatics. 2012; 53: 203
      2. Postoperative delirium in older adults: best practice statement from the American Geriatrics Society.
        J Am Coll Surg. 2015; 220: 136
        • Ebersoldt M.
        • Sharshar T.
        • Annane D.
        Sepsis-associated delirium.
        Intensive Care Med. 2007; 33: 941
        • Prasongsukarn K.
        • Abel J.G.
        • Jamieson W.R.
        • et al.
        The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial.
        J Thorac Cardiovasc Surg. 2005; 130: 93
        • Siddiqi N.
        • Harrison J.K.
        • Clegg A.
        • et al.
        Interventions for preventing delirium in hospitalised non-ICU patients.
        Cochrane Database Syst Rev. 2016; 3: D5563
        • Moheimani H.
        • Yaseri M.
        Dexamethasone reduces postoperative nausea in pediatric upper endoscopy with deep sedation.
        J Pediatr Gastr Nutr. 2019; 69: 281
        • Steiner L.A.
        Postoperative delirium. Part 1.
        Eur J Anaesth. 2011; 28: 628
        • Tremblay P.
        • Gold S.
        Prevention of post-operative delirium in the elderly using pharmacological agents.
        Can Geriatr J. 2016; 19: 113
        • Liu Y.
        • Li X.J.
        • Liang Y.
        • Kang Y.
        Pharmacological prevention of postoperative delirium: a systematic review and meta-analysis of randomized controlled trials.
        Evid Based Complement Alternat Med. 2019; 2019: 9607129
        • Mariscalco G.M.P.
        • Cottini M.M.
        • Zanobini M.M.P.
        • et al.
        Preoperative statin therapy is not associated with a decrease in the incidence of delirium after cardiac operations.
        Ann Thorac Surg. 2012; 93: 1439
        • Moots R.J.
        • Al-Saffar Z.
        • Hutchinson D.
        • et al.
        Old drug, new tricks: haloperidol inhibits secretion of proinflammatory cytokines.
        Ann Rheum Dis. 1999; 58: 585
        • Kalisvaart K.J.
        • de Jonghe J.F.
        • Bogaards M.J.
        • et al.
        Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study.
        J Am Geriatr Soc. 2005; 53: 1658
        • Nishimura K.
        • Harigai M.
        • Omori M.
        • Sato E.
        • Hara M.
        Blood-brain barrier damage as a risk factor for corticosteroid-induced psychiatric disorders in systemic lupus erythematosus.
        Psychoneuroendocrino. 2007; 33: 395
        • Wada K.
        • Yamada N.
        • Sato T.
        • et al.
        Corticosteroid-induced psychotic and mood disorders: diagnosis defined by DSM-IV and clinical pictures.
        Psychosomatics. 2001; 42: 461
        • McIntosh T.
        Beta-endorphin, cortisol and postoperative delirium: a preliminary report.
        Psychoneuroendocrino. 1985; 10: 303
        • Olsson T.
        Activity in the hypothalamic-pituitary- adrenal axis and delirium.
        Dement Geriatr Cogn. 1999; 10: 345
        • Mandell A.J.
        • Chapman L.F.
        • Rand R.W.
        • Walter R.D.
        Plasma corticosteroids: changes in concentration after stimulation of hippocampus and amygdala.
        Science. 1963; 139: 1212
        • Jacobson L.
        • Sapolsky R.
        The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis∗.
        Endocr Rev. 1991; 12: 118
        • De Kloet E.R.
        • Vreugdenhil E.
        • Oitzl M.S.
        • Joels M.
        Brain corticosteroid receptor balance in health and disease.
        Endocr Rev. 1998; 19: 269
        • Holmes M.C.
        • Yau J.L.W.
        • French K.L.
        • Seckl J.R.
        The effect of adrenalectomy on 5-hydroxytryptamine and corticosteroid receptor subtype messenger RNA expression in rat hippocampus.
        Neuroscience. 1995; 64: 327
        • Holmes M.C.
        • French K.L.
        • Seckl J.R.
        Dysregulation of diurnal rhythms of serotonin 5-HT2C and corticosteroid receptor gene expression in the hippocampus with food restriction and glucocorticoids.
        J Neurosci. 1997; 17: 4056
        • Schutsky K.
        • Ouyang M.
        • Castelino C.B.
        • Zhang L.
        • Thomas S.A.
        Stress and glucocorticoids impair memory retrieval via 2-adrenergic, Gi/o-coupled suppression of cAMP signaling.
        J Neurosci. 2011; 31: 14172
        • Newcomer J.W.
        • Craft S.
        • Hershey T.
        • Askins K.
        • Bardgett M.E.
        Glucocorticoid-induced impairment in declarative memory performance in adult humans.
        J Neurosci. 1994; 14: 2047
        • Lupien S.J.
        • de Leon M.
        • de Santi S.
        • et al.
        Cortisol levels during human aging predict hippocampal atrophy and memory deficits.
        Nat Neurosci. 1998; 1: 69
        • Gurevich D.
        • Siegel B.
        • Dumlao M.
        • et al.
        HPA axis responsivity to dexamethasone and cognitive impairment in dementia.
        Prog Neuropsychopharmacol Biol Psychiatry. 1990; 14: 297
        • Belanoff J.K.
        • Gross K.
        • Yager A.
        • Schatzberg A.F.
        Corticosteroids and cognition.
        J Psychiatr Res. 2001; 35: 127
        • Chau S.Y.
        • Mok C.C.
        Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus.
        Neurology. 2003; 61: 104
        • Genis B.
        • Cosar B.
        [Mania associated with the use of Bortezomib and dexamethasone].
        Turk Psikiyatri Derg. 2018; 29: 209
      3. Acute adverse reactions to prednisone in relation to dosage.
        Clin Pharmacol Ther. 1972; 13: 694
        • Chan L.
        • French M.E.
        • Oliver D.O.
        • Morris P.J.
        High- and low-dose prednisolone.
        Transpl P. 1981; 13: 336
        • Galen D.M.
        • Beck M.
        • Buchbinder D.
        Steroid psychosis after orthognathic surgery: a case report.
        J Oral Maxillofac Surg. 1997; 55: 294
        • Prado C.E.
        • Crowe S.F.
        Corticosteroids and cognition: a meta-analysis.
        Neuropsychol Rev. 2019; 29: 288
        • Kuhn E.
        • Du X.
        • McGrath K.
        • et al.
        Validation of a consensus method for identifying delirium from hospital records.
        PLoS One. 2014; 9: e111823
        • Chang J.T.
        • Atayee R.S.
        • Edmonds K.P.
        Identifying patterns of delirium in hospitalized patients on dexamethasone using a chart abstraction tool.
        J Pain Palliat Care Pharmacother. 2018; 32: 30
        • Mu J.L.
        • Lee A.
        • Joynt G.M.
        Pharmacologic agents for the prevention and treatment of delirium in patients undergoing cardiac surgery: systematic review and metaanalysis.
        Crit Care Med. 2015; 43: 194
        • Dieleman J.M.
        Intraoperative high-dose dexamethasone for cardiac surgery.
        JAMA. 2012; 308: 1761
        • Shih A.
        • Jackson K.N.
        Role of corticosteroids in palliative care.
        J Pain Palliat Care Pharmacother. 2007; 21: 69
        • Sandhu G.
        • Farias A.A.
        • Ranade A.
        • Meisels I.
        Altered mental status in a case of multiple myeloma not related to a metabolic cause.
        NDT Plus. 2009; 2: 434
        • Hopkins R.O.
        • Weaver L.K.
        • Pope D.
        • et al.
        Neuropsychological sequelae and impaired health status in survivors of severe acute respiratory distress syndrome.
        Am J Resp Crit Care. 1999; 160: 50
        • Tao R.
        • Wang X.
        • Pang L.
        • et al.
        Pharmacologic prevention of postoperative delirium after on-pump cardiac surgery.
        Medicine. 2018; 97: e12771